- Measured by its ability to induce CXCL1/GRO alpha secretion in HT-29 human colon adenocarcinoma cells.
- The ED50 for this effect is 0.12 to 1.2 ng/mL.
- Measured by its ability to induce IL-6 secretion by NIH-3T3 mouse embryonic fibroblast cells.
|15.1 kDa (monomer)|
|>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.|
|Human embryonic kidney cell, HEK293-derived human IL-17/IL-17A protein Gly24-Ala155|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.|
|Lyophilized from a 0.2 µm filtered solution in PBS.|
|<0.01 EU per 1 µg of the protein by the LAL method.|
|CTLA8, CTLA-8, CTLA8cytotoxic T-lymphocyte-associated serine esterase 8, Cytotoxic T-lymphocyte-associated antigen 8, IL17, IL17A, IL-17A, IL-17Acytotoxic T-lymphocyte-associated protein 8, IL-17CTLA-8, IL17interleukin-17A, interleukin 17 (cytotoxic T-lymphocyte-associated serine esterase 8), interleukin 17A|
|Reconstitute at 100 µg/mL in PBS.|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok